| Guidelines for the use of flow cytometry and cell sorting in immunological studies A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ... European journal of immunology 49 (10), 1457-1973, 2019 | 1862 | 2019 |
| Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes A Ramzy, DM Thompson, KA Ward-Hartstonge, S Ivison, L Cook, ... Cell stem cell 28 (12), 2047-2061. e5, 2021 | 242 | 2021 |
| Regulatory T‐cell heterogeneity and the cancer immune response KA Ward‐Hartstonge, RA Kemp Clinical & translational immunology 6 (9), e154, 2017 | 133 | 2017 |
| Immune cell interplay in colorectal cancer prognosis SE Norton, KA Ward-Hartstonge, ES Taylor, RA Kemp World journal of gastrointestinal oncology 7 (10), 221, 2015 | 33 | 2015 |
| Inclusion of BLIMP-1+ effector regulatory T cells improves the Immunoscore in a cohort of New Zealand colorectal cancer patients: a pilot study KA Ward-Hartstonge, JL McCall, TR McCulloch, AK Kamps, A Girardin, ... Cancer Immunology, Immunotherapy 66, 515-522, 2017 | 28 | 2017 |
| Telomere profiles and tumor-associated macrophages with different immune signatures affect prognosis in glioblastoma NA Hung, RA Eiholzer, S Kirs, J Zhou, K Ward-Hartstonge, AK Wiles, ... Modern Pathology 29 (3), 212-226, 2016 | 28 | 2016 |
| High-dimensional mass cytometric analysis reveals an increase in effector regulatory T cells as a distinguishing feature of colorectal tumors SE Norton, KA Ward-Hartstonge, JL McCall, JKH Leman, ES Taylor, ... The Journal of Immunology 202 (6), 1871-1884, 2019 | 25 | 2019 |
| Tonic-signaling chimeric antigen receptors drive human regulatory T cell exhaustion C Lamarche, K Ward-Hartstonge, T Mi, DTS Lin, Q Huang, A Brown, ... Proceedings of the National Academy of Sciences 120 (14), e2219086120, 2023 | 23 | 2023 |
| A phase 1b open-label dose-finding study of ustekinumab in young adults with type 1 diabetes AK Marwaha, S Chow, AM Pesenacker, L Cook, A Sun, SA Long, ... Immunotherapy advances 2 (1), ltab022, 2022 | 18 | 2022 |
| Prognostic roles for IL‐2‐producing and CD69+ T cell subsets in colorectal cancer patients ES Taylor, JL McCall, S Shen, A Girardin, FM Munro, MA Black, ... International journal of cancer 143 (8), 2008-2016, 2018 | 17 | 2018 |
| Guidelines for standardizing T‐cell cytometry assays to link biomarkers, mechanisms, and disease outcomes in type 1 diabetes JHM Yang, KA Ward‐Hartstonge, DJ Perry, JL Blanchfield, AL Posgai, ... European journal of immunology 52 (3), 372-388, 2022 | 11 | 2022 |
| PTEN is required for human Treg suppression of costimulation in vitro AJ Lam, M Haque, KA Ward‐Hartstonge, P Uday, CM Wardell, JK Gillies, ... European Journal of Immunology 52 (9), 1482-1497, 2022 | 8 | 2022 |
| Regulatory T‐cell heterogeneity KA Ward‐Hartstonge, A Vasanthakumar Clinical & Translational Immunology 7 (3), 2018 | 6 | 2018 |
| Regulatory T-cell heterogeneity and the cancer immune response. Clin Transl Immunol 6: e154 KA Ward-Hartstonge, RA Kemp | 3 | 2017 |
| Immune cell interplay in colorectal cancer prognosis. World J Gastrointest Oncol 7 (10): 221–232 SE Norton, KA Ward-Hartstonge, ES Taylor, RA Kemp | 3 | 2015 |
| Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial D Tatovic, A Marwaha, P Taylor, SJ Hanna, K Carter, WY Cheung, S Luzio, ... Nature Medicine, 1-10, 2024 | 1 | 2024 |
| Inducing an oxidized redox-balance improves anti-tumor CD8+ T cell function JH Oh, RA Cederberg, E Tanaka, L Bopp, T Ser, S Niyyati, AE Patterson, ... bioRxiv, 2023.03. 27.533229, 2023 | | 2023 |
| Changes in immune cell populations following KappaMab, lenalidomide and low‐dose dexamethasone treatment in multiple myeloma SE Norton, T Khong, M Ramachandran, AJ Highton, KA Ward‐Hartstonge, ... Clinical & Translational Immunology 12 (12), e1478, 2023 | | 2023 |
| PTEN is required for human Treg suppression of costimulation AJ Lam, M Haque, KA Ward-Hartstonge, P Uday, CM Wardell, JK Gillies, ... bioRxiv, 2022.03. 06.483188, 2022 | | 2022 |
| Blimp-1+ regulatory T cells in human colorectal cancer KA Ward-Hartstonge University of Otago, 2018 | | 2018 |
Roslyn KempProfessor, University of Otago在 otago.ac.nz 的电子邮件经过验证
